Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2021

01-02-2021 | Pancreatoduodenostomy | Pancreatic Tumors

Relationship between Cancer Diagnosis and Complications Following Pancreatoduodenectomy for Duodenal Adenoma

Authors: Nina L. Eng, MD, Danielle E. Mustin, BS, Brendan P. Lovasik, MD, Michael K. Turgeon, MD, Adriana C. Gamboa, MD, Mihir M. Shah, MD, Kenneth Cardona, MD, Juan M. Sarmiento, MD, Maria C. Russell, MD, Shishir K. Maithel, MD, Jeffrey M. Switchenko, PhD, David A. Kooby, MD

Published in: Annals of Surgical Oncology | Issue 2/2021

Login to get access

Abstract

Background

Pancreatoduodenectomy (PD) for duodenal adenoma (DA) resection may be associated with excessive surgical risk for patients with potentially benign lesions, given the absence of pancreatic duct obstruction. We examined factors associated with final malignant pathology and evaluated the postoperative course of patients with DA versus pancreatic ductal adenocarcinoma (PDAC).

Methods

We retrospectively analyzed patients with DA who underwent PD from 2008 to 2018 and assessed the accuracy rate of preoperative biopsy and factors associated with final malignant pathology. Complications for DA patients were compared with those of matched PDAC patients.

Results

Forty-five consecutive patients who underwent PD for DA were identified, and the preoperative biopsy false negative rate was 29. Factors associated with final malignant pathology included age over 70 years, preoperative biliary obstruction, and common bile duct diameter > 8 mm (p < 0.05). Compared with patients with PDAC (n = 302), DA patients experienced more major complications (31% vs. 15%, p < 0.01), more grade C postoperative pancreatic fistulas (9% vs. 1%, p < 0.01), and greater mortality (7% vs. 2%, p < 0.05). Propensity score matched patients with DA had more major complications following PD (32% vs. 12%, p < 0.05).

Conclusions

Preoperative biopsy of duodenal adenomas is associated with a high false-negative rate for malignancy, and PD for DA is associated with higher complication rates than PD for PDAC. These results aid discussion among patients and surgeons who are considering observation versus PD for DA, especially in younger patients without biliary obstruction, who are less likely to harbor malignancy.
Literature
1.
go back to reference Ma MX, Bourke MJ. Management of duodenal polyps. Best Pract Res Clin Gastroenterol. 2017;31:389–99.CrossRef Ma MX, Bourke MJ. Management of duodenal polyps. Best Pract Res Clin Gastroenterol. 2017;31:389–99.CrossRef
2.
go back to reference Perzin KH, Bridge MF. Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer. 1981;48:799–819.CrossRef Perzin KH, Bridge MF. Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer. 1981;48:799–819.CrossRef
3.
go back to reference Okada K, Fujisaki J, Kasuga A et al. Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance. Am J Gastroenterol. 2011;106:357–64.CrossRef Okada K, Fujisaki J, Kasuga A et al. Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance. Am J Gastroenterol. 2011;106:357–64.CrossRef
4.
go back to reference Heidecke CD, Rosenberg R, Bauer M et al. Impact of grade of dysplasia in villous adenomas of Vater’s papilla. World J Surg. 2002;26:709–14.CrossRef Heidecke CD, Rosenberg R, Bauer M et al. Impact of grade of dysplasia in villous adenomas of Vater’s papilla. World J Surg. 2002;26:709–14.CrossRef
5.
go back to reference Bellizzi AM, Kahaleh M, Stelow EB. The assessment of specimens procured by endoscopic ampullectomy. Am J Clin Pathol. 2009;132:506–13.CrossRef Bellizzi AM, Kahaleh M, Stelow EB. The assessment of specimens procured by endoscopic ampullectomy. Am J Clin Pathol. 2009;132:506–13.CrossRef
6.
go back to reference Adler DG, Qureshi W, Davila R et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. 2006;64:849–54.CrossRef Adler DG, Qureshi W, Davila R et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. 2006;64:849–54.CrossRef
7.
go back to reference Culver E, McIntyre A. Sporadic duodenal polyps: classification, investigation, and management. Endoscopy. 2011;43:144–55.CrossRef Culver E, McIntyre A. Sporadic duodenal polyps: classification, investigation, and management. Endoscopy. 2011;43:144–55.CrossRef
8.
go back to reference Ho CK, Kleeff J, Friess H, Büchler MW. Complications of pancreatic surgery. HPB. 2005;7:99–108.PubMed Ho CK, Kleeff J, Friess H, Büchler MW. Complications of pancreatic surgery. HPB. 2005;7:99–108.PubMed
9.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232:419.CrossRef Yeo CJ, Cameron JL, Lillemoe KD et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232:419.CrossRef
10.
go back to reference Hogg ME, Zenati M, Novak S et al. Grading of surgeon technical performance predicts postoperative pancreatic fistula for pancreaticoduodenectomy independent of patient-related variables. Ann Surg. 2016;264:482–91.CrossRef Hogg ME, Zenati M, Novak S et al. Grading of surgeon technical performance predicts postoperative pancreatic fistula for pancreaticoduodenectomy independent of patient-related variables. Ann Surg. 2016;264:482–91.CrossRef
11.
go back to reference Sánchez-Velázquez P, Muller X, Malleo G et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211–8.CrossRef Sánchez-Velázquez P, Muller X, Malleo G et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211–8.CrossRef
12.
go back to reference Dias-Santos D, Ferrone CR, Zheng H et al. The Charlson age comorbidity index predicts early mortality after surgery for pancreatic cancer. Surgery. 2015;157:881–7.CrossRef Dias-Santos D, Ferrone CR, Zheng H et al. The Charlson age comorbidity index predicts early mortality after surgery for pancreatic cancer. Surgery. 2015;157:881–7.CrossRef
13.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.CrossRef Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.CrossRef
14.
go back to reference Spigelman A, Talbot I, Williams C et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;334:783–5.CrossRef Spigelman A, Talbot I, Williams C et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;334:783–5.CrossRef
15.
go back to reference Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. In Ann Surg. 2004;205–13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. In Ann Surg. 2004;205–13.
16.
go back to reference Clavien PA, Barkun J, De Oliveira ML et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef Clavien PA, Barkun J, De Oliveira ML et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef
17.
go back to reference Bassi C. International study group on pancreatic fistula definition; postoperative pancreatic fistula; an international study group (ISGPF) definition. Surgery. 2005;138:8–13.CrossRef Bassi C. International study group on pancreatic fistula definition; postoperative pancreatic fistula; an international study group (ISGPF) definition. Surgery. 2005;138:8–13.CrossRef
18.
go back to reference Parsons LS. Using SAS software to perform a case-control match on propensity score in an observational study. In: Proceedings of the twenty-fifth annual SAS users group international conference; 2000, p. 1166–71. Parsons LS. Using SAS software to perform a case-control match on propensity score in an observational study. In: Proceedings of the twenty-fifth annual SAS users group international conference; 2000, p. 1166–71.
19.
go back to reference Noun R, Riachy E, Ghorra C et al. The impact of obesity on surgical outcome after pancreaticoduodenectomy. JOP. J Pancreas. (Online) 2008;9:468–76. Noun R, Riachy E, Ghorra C et al. The impact of obesity on surgical outcome after pancreaticoduodenectomy. JOP. J Pancreas. (Online) 2008;9:468–76.
20.
go back to reference Benns M, Woodall C, Scoggins C et al. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol. 2009;16:2565–9.CrossRef Benns M, Woodall C, Scoggins C et al. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol. 2009;16:2565–9.CrossRef
21.
go back to reference Faraj W, Alameddine R, Mukherji D et al. Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice? World J Surg Oncol. 2013;11:131.CrossRef Faraj W, Alameddine R, Mukherji D et al. Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice? World J Surg Oncol. 2013;11:131.CrossRef
22.
go back to reference Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26:734–53.CrossRef Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26:734–53.CrossRef
23.
go back to reference Wellner UF, Kayser G, Lapshyn H et al. A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively. HPB 2010;12:696–702.CrossRef Wellner UF, Kayser G, Lapshyn H et al. A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively. HPB 2010;12:696–702.CrossRef
24.
go back to reference Callery MP, Pratt WB, Kent TS et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surgeons. 2013;216:1–14.CrossRef Callery MP, Pratt WB, Kent TS et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surgeons. 2013;216:1–14.CrossRef
25.
go back to reference Yarandi SS, Runge T, Wang L et al. Increased incidence of benign pancreatic pathology following pancreaticoduodenectomy for presumed malignancy over 10 years despite increased use of endoscopic ultrasound. Diagn Therap Endosc. 2014;2014. Yarandi SS, Runge T, Wang L et al. Increased incidence of benign pancreatic pathology following pancreaticoduodenectomy for presumed malignancy over 10 years despite increased use of endoscopic ultrasound. Diagn Therap Endosc. 2014;2014.
26.
go back to reference Lee CHA, Shingler G, Mowbray NG et al. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom. Anz J Surg. 2018;88:E157–61.CrossRef Lee CHA, Shingler G, Mowbray NG et al. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom. Anz J Surg. 2018;88:E157–61.CrossRef
27.
go back to reference Braga M, Capretti G, Pecorelli N et al. A prognostic score to predict major complications after pancreaticoduodenectomy. Ann Surg. 2011;254:702–8.CrossRef Braga M, Capretti G, Pecorelli N et al. A prognostic score to predict major complications after pancreaticoduodenectomy. Ann Surg. 2011;254:702–8.CrossRef
28.
go back to reference Wiltberger G, Muhl B, Benzing C et al. Preoperative risk stratification for major complications following pancreaticoduodenectomy: identification of high-risk patients. Int J Surg. 2016;31:33–9.CrossRef Wiltberger G, Muhl B, Benzing C et al. Preoperative risk stratification for major complications following pancreaticoduodenectomy: identification of high-risk patients. Int J Surg. 2016;31:33–9.CrossRef
29.
go back to reference Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–211.CrossRef Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–211.CrossRef
30.
go back to reference Hamanaka Y, Nishihara K, Hamasaki T et al. Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery. 1996;119:281–7.CrossRef Hamanaka Y, Nishihara K, Hamasaki T et al. Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery. 1996;119:281–7.CrossRef
Metadata
Title
Relationship between Cancer Diagnosis and Complications Following Pancreatoduodenectomy for Duodenal Adenoma
Authors
Nina L. Eng, MD
Danielle E. Mustin, BS
Brendan P. Lovasik, MD
Michael K. Turgeon, MD
Adriana C. Gamboa, MD
Mihir M. Shah, MD
Kenneth Cardona, MD
Juan M. Sarmiento, MD
Maria C. Russell, MD
Shishir K. Maithel, MD
Jeffrey M. Switchenko, PhD
David A. Kooby, MD
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08767-1

Other articles of this Issue 2/2021

Annals of Surgical Oncology 2/2021 Go to the issue

Health Services Research and Global Oncology

2020 SSO Presidential Address: Surgical Oncology Moonshot